Wall Street News Alert: Trade Alert: ALVR, AGEN

Wall Street News Alert is issuing its "Daily Market Movers Report" for Wednesday morning. It includes: Alvarion Ltd. (NASDAQ: ALVR) and Antigenics Inc. (NASDAQ: AGEN).

For more information, please visit www.WallStreetNewsAlert.com.

Alvarion Ltd. (NASDAQ: ALVR)

Alvarion Ltd. (NASDAQ: ALVR) closed yesterday up 14.97% on over 2.6 million shares traded.

To view the complete release, please visit: http://wallstreetnewsalert.com/fullstory.php?id=1284

June 17, 2009 - Alvarion Ltd. (NASDAQ: ALVR), the world's leading provider of WiMAX and wireless broadband solutions, today announced it was selected by U.S. broadband wireless operator, Open Range Communications Inc., for the nation's largest Rural Utilities Service (RUS) funded deployment spanning 17 states, 546 rural communities, and reaching up to 6 million people. With this new broadband wireless network, Open Range will begin offering state-of-the-art 4G services to un-served and underserved customers across rural America in the fourth quarter of this year.

As part of this contract, expected to be more than US$100 million over a five-year implementation, Alvarion will provide radio access equipment, customer devices (CPE) and systems integration for Open Range's broadband wireless network. In addition to selecting Alvarion for its market-leading WiMAX platform, Open Range will rely on Alvarion's industry leadership and experience for the end-to-end integration of the Open Range network solution, creating a best-of-breed 4G network in rural America.

About the company:

Alvarion is the largest WiMAX pure-player with the most extensive WiMAX customer base and over 250 commercial deployments around the globe. Committed to growing the WiMAX market, the company offers solutions for a wide range of frequency bands supporting a variety of business cases. Through its OPEN WiMAX strategy, superior IP and OFDMA know-how, and ability to deploy end-to-end turnkey WiMAX projects, Alvarion is shaping the new wireless broadband experience (www.alvarion.com).

Antigenics Inc. (NASDAQ: AGEN)

Antigenics Inc. (NASDAQ: AGEN) closed yesterday down 5.83% on over 1.8 million shares traded.

To view the complete release, please visit: http://wallstreetnewsalert.com/fullstory.php?id=1287

June 17, 2009 - Antigenics Inc. (NASDAQ: AGEN) today announced that GlaxoSmithKline (GSK) has launched a Phase 3 study with the world's most clinically-advanced malaria vaccine, RTS,S, which contains Antigenics' QS-21 Stimulon adjuvant.

"There are now approximately 15 vaccines containing QS-21 in clinical trials of which four have now progressed into Phase 3 studies across multiple indications including non-small cell lung cancer, melanoma and malaria," said Garo H. Armen, PhD, chairman and CEO of Antigenics. "Today's announcement demonstrates that QS-21 is a critical adjuvant in the development of therapeutic and prophylactic vaccines and is expected to be a significant contributor to Antigenics future royalty income in the event of successful commercialization."

QS-21 is a key component in several of GSK's proprietary adjuvant systems, which play an integral role in a new generation of GSK vaccines currently in development. Under the terms of the license and supply agreements announced in July 2006, GSK will make payments contingent upon successful milestone achievements, and will pay royalties to Antigenics on net sales for a period of at least 10 years after first commercial sale.

Recent Phase 2 malaria studies showed that, over an eight-month follow-up period, RTS,S reduced clinical episodes of malaria by 53 percent and had a promising safety and tolerability profile when used alongside standard infant vaccines. The Phase 3 trial builds on more than 10 years of clinical research in Africa, including the first proof-of-concept study in children in 2004 and a proof-of-concept study in infants in 2007.

Receive our free mobile stock alerts formatted especially for your cell phone by texting the word "press" in the subject line to 68494.

*** This free service can be discontinued at any time by replying to any one of the alerts with the word "stop".

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of often overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 100 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com and select the "join now" button.

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its' Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks

WSCF has not been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. However, WSCF may receive compensation for future services. Any additional compensation will be disclosed at such time that WSCF is aware of a clients desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

CONTACT: Wall Street News Alert e-mail: info@wallstreetnewsalert.com WWW: http://www.wallstreetnewsalert.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

Related terms: africa, annual report, art, bandwidth, broker, business, cancer, ceo, children, clinical, commercial, communications, contract, dealer, email, e-mail, investment, investment opinion, market, nasdaq, profit, radio, research, securities, security, trade, trial, utilities, vaccine, web, wireless